Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus

Recruiting

Phase 1

ATTO-1310Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus

Sponsor:

Attovia Therapeutics Inc

Code:

NCT06787586

Conditions

Normal Volunteers

Atopic Dermatitis (AD)

Atopic Eczema

Chronic Pruritus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

ATTO-1310

ATTO-1310 Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-08. This information was provided to ClinicalTrials.gov by Attovia Therapeutics Inc on 2025-09-04.